Kumar Neil
SEC CIK 1742485 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | CEO, Pres, Dir | 495.7K | — | $121.21M | 86 | 2021-08-16 | 2026-09-17 |
Most active insiders at BBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kumar Neil | CEO, Dir | — | $61.54M |
| 2 | Cook Jennifer E. | Dir | — | $21.92M |
| 3 | MCCORMICK FRANK | Dir | — | $13.31M |
| 4 | Lo Andrew | Dir | — | $6.32M |
| 5 | Ellis Andrea | Dir | — | $5.65M |
| 6 | Valantine Hannah | Dir | — | $4.37M |
| 7 | DANIELS RONALD J | Dir | — | $3.89M |
| 8 | Trimarchi Thomas | Pres, CFO | — | $3.03M |
| 9 | Scott Randal W. | Dir | — | $2.09M |
| 10 | Apuli Maricel | CAO | — | $621.7K |
Transactions 86
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2026-09-21 18:21 | 2026-09-17 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $69.08 | -10.0K | 495.7K | -2% | -$690.8K |
| MT | 2026-08-20 16:31 | 2026-08-18 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $82.53 | -35.0K | 243.3K | -13% | -$2.89M |
| MTI | 2026-08-20 16:31 | 2026-08-19 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $84.03 | -10.0K | 505.7K | -2% | -$840.3K |
| DM | 2026-08-18 18:02 | 2026-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | M - OptEx | — | +71.2K | 314.5K | +29% | — |
| D | 2026-08-18 18:02 | 2026-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | F - Tax | $79.86 | -36.2K | 278.3K | -12% | -$2.89M |
| MTI | 2026-06-08 18:01 | 2026-06-04+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $67.67 | -80.0K | 4.32M | -2% | -$5.41M |
| MT | 2026-05-26 16:54 | 2026-05-21 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $69.44 | -26.1K | 243.3K | -10% | -$1.81M |
| DM | 2026-05-19 16:27 | 2026-05-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | M - OptEx | — | +71.2K | 305.7K | +30% | — |
| D | 2026-05-19 16:27 | 2026-05-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | F - Tax | $66.13 | -36.2K | 269.4K | -12% | -$2.40M |
| MTI | 2026-05-11 17:15 | 2026-05-07+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $67.40 | -80.0K | 4.36M | -2% | -$5.39M |
| MTI | 2026-04-13 18:06 | 2026-04-09+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $74.61 | -80.0K | 4.40M | -2% | -$5.97M |
| MI | 2026-03-16 | 2026-03-12+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $68.76 | -80.0K | 4.46M | -2% | -$5.50M |
| M | 2026-02-23 | 2026-02-19 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $71.39 | -28.1K | 234.5K | -11% | -$2.00M |
| DM | 2026-02-18 | 2026-02-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | M - OptEx | — | +64.7K | 262.3K | +33% | — |
| D | 2026-02-18 | 2026-02-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | F - Tax | $75.25 | -31.0K | 262.5K | -11% | -$2.33M |
| MI | 2026-02-12 | 2026-02-10+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $71.86 | -80.0K | 701.5K | -10% | -$5.75M |
| MI | 2026-01-12 | 2026-01-08+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $75.54 | -80.0K | 4.54M | -2% | -$6.04M |
| D | 2025-12-16 | 2025-12-12 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | M - OptEx | — | +61.0K | 289.8K | +27% | — |
| DM | 2025-12-16 | 2025-12-15 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale+OE | $74.64 | -30.0K | 230.5K | -12% | -$2.24M |
| D | 2025-12-16 | 2025-12-12 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | F - Tax | $75.15 | -31.0K | 258.8K | -11% | -$2.33M |
| MI | 2025-12-08 | 2025-12-04+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $73.86 | -80.0K | 755.7K | -10% | -$5.91M |
| M | 2025-11-24 | 2025-11-20 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $65.84 | -26.2K | 234.2K | -10% | -$1.72M |
| DM | 2025-11-18 | 2025-11-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | M - OptEx | — | +64.7K | 276.2K | +31% | — |
| D | 2025-11-18 | 2025-11-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | F - Tax | $66.39 | -32.9K | 254.9K | -11% | -$2.18M |
| MI | 2025-11-10 | 2025-11-06+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $62.29 | -80.0K | 4.62M | -2% | -$4.98M |
| MI | 2025-10-10 | 2025-10-08+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $54.79 | -80.0K | 4.66M | -2% | -$4.38M |
| MI | 2025-09-08 | 2025-09-04+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $52.20 | -80.0K | 4.68M | -2% | -$4.18M |
| MT | 2025-08-22 | 2025-08-20 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $48.82 | -26.2K | 223.5K | -10% | -$1.28M |
| D | 2025-08-19 | 2025-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | M - OptEx | — | +64.7K | 282.1K | +30% | — |
| D | 2025-08-19 | 2025-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | F - Tax | $51.32 | -32.9K | 249.2K | -12% | -$1.69M |
| MTI | 2025-08-11 | 2025-08-07+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $45.84 | -80.0K | 4.75M | -2% | -$3.67M |
| MTI | 2025-07-03 | 2025-07-01+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $42.63 | -80.0K | 977.3K | -8% | -$3.41M |
| DT | 2025-05-20 | 2025-05-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | M - OptEx | — | +64.7K | 276.4K | +31% | — |
| DT | 2025-05-20 | 2025-05-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | F - Tax | $33.84 | -32.9K | 243.6K | -12% | -$1.11M |
| DTI | 2025-05-20 | 2025-05-20 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale+OE | $33.40 | -75.0K | 4.80M | -2% | -$2.50M |
| DMT | 2025-05-20 | 2025-05-19 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale+OE | $33.33 | -26.2K | 217.8K | -11% | -$871.7K |
| TI | 2025-04-24 | 2025-04-22 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $34.11 | -75.0K | 4.87M | -2% | -$2.56M |
| TI | 2025-03-27 | 2025-03-25 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $36.87 | -75.0K | 4.95M | -1% | -$2.77M |
| MTI | 2025-02-27 | 2025-02-25 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $33.57 | -75.0K | 5.06M | -1% | -$2.52M |
| DT | 2025-02-19 | 2025-02-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | M - OptEx | — | +55.5K | 267.3K | +26% | — |
| DMT | 2025-02-19 | 2025-02-19 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale+OE | $36.14 | -31.5K | 211.7K | -13% | -$1.14M |
| DT | 2025-02-19 | 2025-02-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | F - Tax | $34.90 | -24.0K | 243.3K | -9% | -$837.5K |
| MTI | 2025-01-30 | 2025-01-28+ | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $36.32 | -600.0K | 5.10M | -11% | -$21.79M |
| 2024-12-27 | 2024-12-24 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | G - Gift | $0.00 | -4.69M | 211.7K | -96% | $0 | |
| I | 2024-12-27 | 2024-12-24 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | G - Gift | $0.00 | +4.69M | 5.70M | +463% | $0 |
| MT | 2024-11-20 | 2024-11-19 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale | $22.42 | -27.4K | 4.90M | -0.6% | -$613.9K |
| D | 2024-11-19 | 2024-11-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | M - OptEx | — | +55.5K | 4.95M | +1% | — |
| D | 2024-11-19 | 2024-11-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | F - Tax | $23.72 | -28.1K | 4.92M | -0.6% | -$667.7K |
| DMT | 2024-08-20 | 2024-08-19 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | S - Sale+OE | $24.69 | -27.4K | 4.90M | -0.6% | -$676.3K |
| DT | 2024-08-20 | 2024-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | M - OptEx | — | +55.5K | 4.95M | +1% | — |
| DT | 2024-08-20 | 2024-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Dir | F - Tax | $24.40 | -28.1K | 4.92M | -0.6% | -$686.8K |
| D | 2024-05-17 | 2024-05-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +60.7K | 4.93M | +1% | — |
| D | 2024-05-17 | 2024-05-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $31.04 | -30.7K | 4.90M | -0.6% | -$954.4K |
| D | 2024-02-21 | 2024-02-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $37.21 | -47.9K | 4.87M | -1.0% | -$1.78M |
| D | 2024-02-21 | 2024-02-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +102.2K | 4.92M | +2% | — |
| D | 2023-11-20 | 2023-11-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +102.2K | 4.92M | +2% | — |
| DM | 2023-11-20 | 2023-11-17 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale+OE | $29.10 | -51.6K | 4.81M | -1% | -$1.50M |
| D | 2023-11-20 | 2023-11-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $28.86 | -50.7K | 4.86M | -1% | -$1.46M |
| D | 2023-08-18 | 2023-08-17 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale+OE | $28.59 | -51.6K | 4.81M | -1% | -$1.47M |
| D | 2023-08-18 | 2023-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +102.2K | 4.92M | +2% | — |
| D | 2023-08-18 | 2023-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $29.80 | -50.7K | 4.86M | -1% | -$1.51M |
| D | 2023-05-18 | 2023-05-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +102.2K | 4.92M | +2% | — |
| D | 2023-05-18 | 2023-05-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $14.09 | -50.7K | 4.86M | -1% | -$714.3K |
| D | 2023-05-18 | 2023-05-17 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale+OE | $14.01 | -51.6K | 4.81M | -1% | -$722.2K |
| I | 2023-05-05 | 2023-05-03 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale | $14.18 | -120.0K | 1.01M | -11% | -$1.70M |
| I | 2023-04-07 | 2023-04-05 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale | $15.46 | -120.0K | 1.13M | -10% | -$1.86M |
| I | 2023-03-03 | 2023-03-03 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale | $10.96 | -120.0K | 1.25M | -9% | -$1.32M |
| D | 2023-02-21 | 2023-02-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $12.64 | -23.9K | 4.86M | -0.5% | -$302.2K |
| D | 2023-02-21 | 2023-02-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +68.7K | 4.88M | +1% | — |
| D | 2023-02-21 | 2023-02-17 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale+OE | $12.70 | -44.8K | 4.81M | -0.9% | -$568.9K |
| I | 2023-02-06 | 2023-02-03 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale | $11.01 | -120.0K | 1.37M | -8% | -$1.32M |
| I | 2023-01-06 | 2023-01-05 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale | $7.67 | -120.0K | 1.49M | -7% | -$920.4K |
| I | 2022-12-21 | 2022-12-21 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale | — | -200.0K | 995.7K | -17% | — |
| D | 2022-11-18 | 2022-11-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $9.64 | -34.1K | 4.85M | -0.7% | -$328.4K |
| D | 2022-11-18 | 2022-11-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +68.7K | 4.88M | +1% | — |
| D | 2022-11-18 | 2022-11-17 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | S - Sale+OE | $9.40 | -34.6K | 4.81M | -0.7% | -$325.6K |
| D | 2022-08-18 | 2022-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $11.08 | -27.7K | 4.81M | -0.6% | -$306.9K |
| D | 2022-08-18 | 2022-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +68.7K | 4.84M | +1% | — |
| D | 2022-05-18 | 2022-05-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +68.7K | 4.80M | +1% | — |
| D | 2022-05-18 | 2022-05-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $6.74 | -23.8K | 4.77M | -0.5% | -$160.1K |
| D | 2022-02-18 | 2022-02-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $8.84 | -3,085 | 4.73M | -0.1% | -$27.3K |
| D | 2022-02-18 | 2022-02-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +7,524 | 4.73M | +0.2% | — |
| D | 2021-11-18 | 2021-11-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +7,523 | 4.73M | +0.2% | — |
| D | 2021-11-18 | 2021-11-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $47.25 | -3,730 | 4.72M | -0.1% | -$176.2K |
| D | 2021-08-18 | 2021-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | F - Tax | $49.48 | -3,730 | 4.72M | -0.1% | -$184.6K |
| D | 2021-08-18 | 2021-08-16 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO, Pres, Dir | M - OptEx | — | +7,523 | 4.72M | +0.2% | — |
Purchase Sale Sale after option exercise All abbreviations